Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: G29687103
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 13,326,887
- Percent of class
- 13.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-24-000106
- Form type
- SC 13G
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership